Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	455	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	1735	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	2483	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	16198	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	23786	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	24272	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	29524	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	31501	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	34225	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	34555	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	41559	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	43586	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	44523	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	45822	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	46006	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	46579	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	47554	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	49503	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	51209	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	51238	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	51522	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	51849	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	52135	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	52723	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	53593	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	54331	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	54762	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	54803	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	54976	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	55192	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	55905	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	56140	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	57856	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	58828	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	58881	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	59294	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	59835	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	62291	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	63135	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	63343	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	64232	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	64687	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	66681	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	67586	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	67676	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	68882	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	69289	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	70690	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	71615	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	71663	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	72014	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	72020	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	72024	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	72621	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	72795	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	73015	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	73882	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	74544	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	74923	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	75524	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	76276	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	76289	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	76636	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	76894	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	76903	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	77399	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	78375	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	78672	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	78914	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	79296	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	79596	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	81526	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	81537	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	81796	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	82899	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	83828	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	83870	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	84679	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	85165	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	85380	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	87312	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	87868	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	89231	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	89791	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	89811	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	90519	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	91008	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	91030	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	91196	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	91693	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	91717	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	91880	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	92088	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	92219	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	92384	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	92499	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	93968	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	94196	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	94819	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	94873	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	96726	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	97134	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	98252	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	98417	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	98968	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	99520	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	100803	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	101879	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	101892	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	102030	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	102867	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	103053	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	103445	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	105007	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	106927	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	107356	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	107360	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	107709	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	107725	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	107824	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	108635	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	108870	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	111355	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	111365	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	112604	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	112839	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	113767	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	115311	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	115564	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	115939	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	116497	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	116611	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	117034	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	117148	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	117230	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	117459	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	117992	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	118113	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	118504	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	118771	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	118906	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	119633	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	119752	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	120009	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	120275	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	120648	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	121798	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	122466	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	122667	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	123012	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	123172	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	123237	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	123316	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	123921	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	124527	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	124671	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125154	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125193	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125676	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125736	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125750	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125977	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125993	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	125995	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126341	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126588	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126691	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126823	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126866	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126875	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126951	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	126964	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	127056	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	127071	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	128329	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	128343	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	128988	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	129498	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	130601	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	130635	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	130762	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	130948	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	131296	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	131460	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	134278	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	134539	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	135857	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	136076	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	136281	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	136507	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	136546	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	137071	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	137137	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	139257	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	139536	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	140910	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	140978	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	141188	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	142087	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	lithocholate glycine conjugate	142239	Peak area normalized	Sample	male

Return to search page